Skip to content

Investigating the effects of dexmedetomidine infusion on sadation

Investigating the effects of dexmedetomidine infusion compared to placebo on sedation in patients undergoing upper limb surgery with nerve blocks

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20170516033992N17
Enrollment
60
Registered
2025-09-27
Start date
2025-10-22
Completion date
Unknown
Last updated
2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Upper limb surgery with nerve blocks.

Interventions

Intervention 1: Intervention group:After nerve block, dexmedetomidine infusion will be given at a concentration of 4 micrograms/cc at a dose of 0.1 micrograms/kg for 10 minutes and then 0.05 microgram

Sponsors

Oroumia University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Adult patients (18-65 years) Candidates for elective upper limb surgery

Exclusion criteria

Exclusion criteria: Patients who refuse to participate in the trial Pregnancy Breastfeeding Severe renal or hepatic impairment Cardiovascular impairment Cognitive impairment Inability to cooperate Having a history of allergy to dexmethodamide

Design outcomes

Primary

MeasureTime frame
Sedation Quality During Surgery in Patients Undergoing Upper Limb Surgery Under Nerve Blocks. Timepoint: At the initiation, during the maintenance infusion, and at the end of sedation. Method of measurement: Ramsay Sedation Scale criteria.;Duration of sedation. Timepoint: Up to 24 hours after surgery. Method of measurement: Kornometer (minutes).;Pain after surgery. Timepoint: Up to 24 hours after surgery. Method of measurement: Visual analogue scale (VAS).

Secondary

MeasureTime frame
The first time of analgesic. Timepoint: Up to 24 hours after the surgery. Method of measurement: Kornometere (minutes).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr.Tohid Karami

Oroumia University of Medical Sciences

karami.t@umsu.ac.ir+98 44 3222 2010

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026